Skip to main content
TipRanks
Go Ultimate75% OFF

Bio-Rad Laboratories (BIO) Stock Statistics & Valuation Metrics

931 Followers

Total Valuation

Bio-Rad Laboratories has a market cap or net worth of $9.74B. The enterprise value is $9.87B.

Market Cap
$9.74B
Enterprise Value
$9.87B

Share Statistics

Bio-Rad Laboratories has 21,832,130 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
21,832,130
Owned by Insiders
37.17%
Owned by Institutions
54.86%

Financial Efficiency

Bio-Rad Laboratories’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 2.04%.

Return on Equity (ROE)
0.10
Return on Assets (ROA)
0.07
Return on Invested Capital (ROIC)
2.04%
Return on Capital Employed (ROCE)
0.03
Revenue Per Employee
346.74K
Profits Per Employee
102.00K
Employee Count
7,450
Asset Turnover
0.24
Inventory Turnover
1.67

Valuation Ratios

The current PE Ratio of Bio-Rad Laboratories is 9.41. Bio-Rad Laboratories’s PEG ratio is 0.03.

PE Ratio
9.41
PS Ratio
3.73
PB Ratio
1.27
Price to FCF
29.35
Price to Operating Cash Flow
20.55
PEG Ratio
0.03

Income Statement

In the last 12 months, Bio-Rad Laboratories had revenue of 2.58B and earned 759.90M in profits. Earnings per share was 27.87.

Revenue
2.58B
Gross Profit
1.34B
Operating Income
270.50M
Pretax Income
995.50M
Net Income
759.90M
EBITDA
1.21B
Earnings Per Share (EPS)
27.87

Cash Flow

In the last 12 months, operating cash flow was 468.10M and capital expenditures -139.00M, giving a free cash flow of 329.10M billion.

Operating Cash Flow
468.10M
Free Cash Flow
329.10M
Free Cash Flow per Share
12.29

Dividends & Yields

Bio-Rad Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
3.40%
Earnings Yield
10.63%

Stock Price Statistics

Beta
0.81
52-Week Price Change
17.80%
50-Day Moving Average
372.95
200-Day Moving Average
317.11
Relative Strength Index (RSI)
42.22
Average Volume (3m)
255.79K

Important Dates

Bio-Rad Laboratories upcoming earnings date is Feb 18, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 04, 2026
Next Earnings Date
Feb 18, 2027
Ex-Dividend Date
―

Financial Position

Bio-Rad Laboratories as a current ratio of 5.62, with Debt / Equity ratio of 20.54%

Current Ratio
5.62
Quick Ratio
4.19
Debt to Market Cap
0.17
Net Debt to EBITDA
0.83
Interest Coverage Ratio
5.52

Taxes

In the past 12 months, Bio-Rad Laboratories has paid 235.60M in taxes.

Income Tax
235.60M
Effective Tax Rate
0.24

Enterprise Valuation

Bio-Rad Laboratories EV to EBITDA ratio is 7.13, with an EV/FCF ratio of 32.10.

EV to Sales
4.07
EV to EBITDA
7.13
EV to Free Cash Flow
32.10
EV to Operating Cash Flow
22.57

Balance Sheet

Bio-Rad Laboratories has $1.66B in cash and marketable securities with $1.36B in debt, giving a net cash position of $300.90M billion.

Cash & Marketable Securities
$1.66B
Total Debt
$1.36B
Net Cash
$300.90M
Net Cash Per Share
$13.78
Tangible Book Value Per Share
$258.61

Margins

Gross margin is 51.26%, with operating margin of 4.59%, and net profit margin of 39.45%.

Gross Margin
51.26%
Operating Margin
4.59%
Pretax Margin
50.92%
Net Profit Margin
39.45%
EBITDA Margin
57.14%
EBIT Margin
52.34%

Analyst Forecast

The average price target for Bio-Rad Laboratories is $440.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
$440.00
Price Target Upside
22.84% Upside
Analyst Consensus
Moderate Buy
Analyst Count
1
Revenue Growth Forecast
1.38%
EPS Growth Forecast
―

Scores

Smart Score
1
AI Score
71